Search clinical trials for: Surufatinib Toripalimab AG

Total 898 results

QLT Inc.

Terminated

A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis

End Stage Renal Disease

United States
Shanghai Chest Hospital
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer

NSCLC

China
Sun Yat-sen University

Recruiting

Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM

Colorectal Cancer Liver Metastases

China
Agios Pharmaceuticals, Inc.

Completed

A Pharmacokinetic Study of Mitapivat in Participants With Moderate Hepatic Impairment Compared to Matched Healthy Control Participants With Normal Hepatic Function

Moderate Hepatic Impairment

United States
Sun Yat-sen University

Recruiting

Toripalimab With or Without Celecoxib as Neoadjuvant Therapy in Resectable dMMR/MSI-H Colorectal Cancer (PICC)

Colorectal Cancer | Neoadjuvant Therapy | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)

China
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

The Recombinant Humanized Anti-TIGIT Monoclonal Antibody (JS006) Monotherapy and in Combination With Toripalimab in Patients With Advanced Tumor

Advanced Tumors

China
NYU Langone Health

Recruiting

Modulating Movement Intention Via Cortical Stimulation

Seizures | Seizure Disorder | Psychogenic Movement Disorder

United States
Eye & ENT Hospital of Fudan University
Changhai Hospital; Shanghai Zhongshan Hospital; Fujian Medical University Union... and other collaborators

Recruiting

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

Recurrent Nasopharyngeal Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Toripalimab for High-risk Locally Advanced Cervical Cancer

Cervical Cancers

China
First Affiliated Hospital of Zhejiang University
Shanghai Longfine Biotechnology Co., Ltd.; TopAlliance

Not yet recruiting

A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

Triple-negative Breast Cancer

China
Nanfang Hospital, Southern Medical University

Not yet recruiting

Toripalimab Maintenance for Locally Advanced Head and Neck Squamous Cell Carcinoma

Locally Advanced Head and Neck Squamous Cell Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Active, not recruiting

Donafenib and Toripalimab Combined With TACE in Patients With Unresectable Hepatocellular Carcinoma

Unresectable Hepatocellular Carcinoma

China
Coherus Biosciences, Inc.

Recruiting

Study of CHS-114 in Participants With Advanced Solid Tumors

Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma

United States
Lund University
Skane University Hospital; Vinnova; Carbiotix AB

Active, not recruiting

Arabinoxylan-oligosaccharides (AXOS) for the Management of Type-2 Diabetes

Diabetes Type 2

Sweden
Rigshospitalet, Denmark
Testcenter Danmark, Statens Serum Institut; Copenhagen Emergency Medical Services

Completed

Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test

Covid19 | SARS-CoV-2 | Rapid Antigen Test

Denmark
Somerset NHS Foundation Trust

Unknown

Somerset and South Essex Coronavirus Antigen Testing (SOCRATES)

SARS-CoV 2 | COVID

United Kingdom
Marco Catarci
Associazione Chirurghi Ospedalieri Italiani

Not yet recruiting

Polihexanide SSIs Measures Bundle (PSMB) During Enhanced Recovery After Major Digestive Surgery (POSSIBLE)

Surgical Site Infection | Surgical Procedures, Operative

Italy
Sun Yat-sen University

Recruiting

Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma

Metastatic | Adenocarcinoma of Small Intestine | Appendix Carcinoma

China
Hangzhou Kaiyuan Suixi Medical Technology Co., Ltd

Completed

Clinical Trial for Effectiveness and Safety Evaluation of Hemodiafilter

Renal Failure Chronic

China
Allgenesis Biotherapeutics Inc.
ORA, Inc.

Completed

A Study of AG-80308 in Dry Eye Patients

Dry Eye Disease

United States
Qure Healthcare, LLC
GlycoMark, Inc

Completed

Glucose Control Using 1,5-AG Testing (GLUCAR)

Diabetes

United States
Agios Pharmaceuticals, Inc.

Terminated

A Safety and Tolerability Study of AG-519 in Healthy Subjects

Anemia

United Kingdom
Molnlycke Health Care AB

Completed

Evaluation of Antimicrobial Soft Silicone, Silver Containing, Foam Dressing, Mepilex Border Ag, in Second Degree Burns

Burns

Sweden
China Medical University, China
Beijing Bio-Targeting Therapeutics Technology Co., Ltd

Not yet recruiting

A Clinical Study of BioTTT001 in Combination With SOX and Toripalimab in Patients With Gastric Cancer

Gastric Cancer, Metastatic
National Institutes of Health Clinical Center (CC)
National Heart, Lung, and Blood Institute (NHLBI); Agios Pharmaceuticals, Inc.

Completed

A Dose-Finding Study of AG-348 in Sickle Cell Disease

Sickle Cell Disease

United States
Universiti Putra Malaysia
UMC Utrecht; Ministry of Health, Malaysia

Completed

Value-based Emotion-focused Educational Programme to Reduce Diabetes-related Distress (VEMOFIT)

Type 2 Diabetes Mellitus
Molnlycke Health Care AB

Completed

TITLE: An Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up (PMCF) Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU, When Using Mepilex Transfer Ag as Intended (MxT Ag 05)

Diabetic Foot Ulcers

United Kingdom
Molnlycke Health Care AB

Completed

Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing

Inflammation | Burns | Ulcers

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)

Head and Neck Squamous Cell Carcinoma

China
Sun Yat-sen University
Xiangya Hospital of Central South University; Wuhan University; Zhujiang Hospital and other collaborators

Recruiting

Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007) (EC-CRT-007)

Locally Advanced Esophageal Squamous Cell Carcinoma

China
Agios Pharmaceuticals, Inc.

Completed

A Phase I Study of AG-348 in Healthy Volunteers (AG-348 SAD)

Healthy Volunteer

United States
Columbia University
National Institute of Mental Health (NIMH)

Enrolling by invitation

Adolescent Depression Screening and Treatment in Mozambican Primary Care

Depression | Adolescent Behavior

Mozambique
Shanghai Ninth People's Hospital Affiliated to...

Recruiting

Neoadjuvant and Adjuvant Toripalimab and Cetuximab in Patients With Recurrent, Resectable Squamous Cell Carcinoma of Head and Neck: a Prospective, Single-arm,Phase II Study

Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma

China
Coherus Biosciences, Inc.
Shanghai Junshi Bioscience Co., Ltd.; Medpace, Inc.

Active, not recruiting

Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Hepatocellular Carcinoma | Non-Small Cell Lung Cancer | Advanced Solid Tumor

United States
Agenus Inc.

Completed

Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes

Herpes Simplex Type 2

United States
University Hospital, Geneva

Terminated

Investigating Reduction of aCute heArt Failure Readmission With Lung UltraSound-preliminary Trial (Pre-IcarUS)

Acute Heart Failure

Switzerland
Peking University
Huantai Maternal and Child Health Care Hospital

Unknown

Post-market Surveillance Study of an Infant Formula Containing Moderately Hydrolyzed Protein and Low Lactose

Gastrointestinal Dysfunction | Infant Nutrition Disorders

China
University of Zurich

Unknown

Clinical Application of Sensimed Triggerfish Sensor (TS) With Wireless Signal Transmission for Continuous Intraocular Pressure Measurement

Glaucoma

Switzerland
West German Center of Diabetes and Health
gbo Medizintechnik AG

Completed

HTEMS Treatment of Diabetic Polyneuropathy (HTEMS-RCT)

Diabetic Polyneuropathy

Germany
University of Zurich

Completed

Effectiveness of Automated Locomotor Training in Patients With Acute Incomplete Spinal Cord Injury: A Multicenter Trial

Spinal Cord Injuries

Switzerland, Spain, Germany
Yongchang Zhang

Completed

Toripalimab Combined With Double Platinum Based Chemotherapy for Potentially Resectable Non-driver Gene Mutation Non-small Cell Lung Cancer

Advanced Non Small Cell Lung Cancer

China
Shouyao Holdings (Beijing) Co. LTD

Recruiting

Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer

Advanced Pancreatic Cancer

China
Hutchmed

Recruiting

A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer

China
University of Liege
Therapiezentrum Burgau

Not yet recruiting

rTMS and EEG in DOC Patients

Disorder of Consciousness

Belgium, Germany
Xiangya Hospital of Central South University

Recruiting

Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma

Hepatocellular Carcinoma

China
Zhejiang Cancer Hospital

Recruiting

Clinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Combined With GEMOX Regimen

Advanced Biliary Tract Tumors

China
Wayne State University

Withdrawn

Mepilex Ag vs. Xeroform in Pediatric Patients That Sustain Partial Thickness Burn Injury

Second-degree Burn

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

HIV Infections | HIV Seronegativity

United States
National Institute of Allergy and Infectious Diseases...
Immuno-US

Completed

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules

HIV Infections

United States

3

Subscribe